Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001178913-11-000361
Filing Date
2011-02-07
Accepted
2011-02-07 16:04:17
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zk1109408.htm 10-K/A 960204
2 REGULATION S STOCK PURCHASE AGREEMENT BETWEEN THE COMPANY AND 1568934 ONTARIO LI exhibit_10-11.htm EX-10.11 69078
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF SAM SHLOMO ELIMELECH exhibit_31-1.htm EX-31.1 9358
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF GAI MAR-CHAIM exhibit_31-2.htm EX-31.2 9257
5 SECTION 1350 CERTIFICATION OF SAM SHLOMO ELIMELECH AND GAI MAR-CHAIM exhibit_32.htm EX-32 5935
  Complete submission text file 0001178913-11-000361.txt   1055276
Mailing Address 350 S. CENTER STREET SUITE 500 RENO NV 89501
Business Address 350 S. CENTER STREET SUITE 500 RENO NV 89501 775-333-5997
ANDAIN, INC. (Filer) CIK: 0001321502 (see all company filings)

EIN.: 202066406 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51216 | Film No.: 11578671
SIC: 2834 Pharmaceutical Preparations